Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peinan Liu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 9, 2024
Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signaturesLidan Chang, Dandan Liu, Xuyan Zhao, et al.
Clinical Breast Cancer|September 18, 2024
Analysis of the Relationship Between Primary Tumor Site and Clinicopathological Characteristics and Survival Prognosis of Breast Cancer Patients Based on SEER DatabaseYumeng Wei, Peinan Liu, Xingyu Liu, et al.
Journal of Cancer Research and Clinical Oncology|May 30, 2024
Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?Dandan Liu, Lidan Chang, Qian Hao, et al.
Journal of Cancer Research and Clinical Oncology|July 31, 2024
Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancerLidan Chang, Dandan Liu, Qian Hao, et al.
Breast Cancer (Tokyo, Japan)|December 27, 2024
Identifying subgroups of ypN1 breast cancer patients who may exempt from axillary lymph node dissection after neoadjuvant chemotherapy: insights from a large cohort studyPeinan Liu, Dandan Liu, Changying Zhao, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 9, 2024
Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signaturesLidan Chang, Dandan Liu, Xuyan Zhao, et al.
Clinical Breast Cancer|September 18, 2024
Analysis of the Relationship Between Primary Tumor Site and Clinicopathological Characteristics and Survival Prognosis of Breast Cancer Patients Based on SEER DatabaseYumeng Wei, Peinan Liu, Xingyu Liu, et al.
Journal of Cancer Research and Clinical Oncology|May 30, 2024
Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?Dandan Liu, Lidan Chang, Qian Hao, et al.
Journal of Cancer Research and Clinical Oncology|July 31, 2024
Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancerLidan Chang, Dandan Liu, Qian Hao, et al.
Breast Cancer (Tokyo, Japan)|December 27, 2024
Identifying subgroups of ypN1 breast cancer patients who may exempt from axillary lymph node dissection after neoadjuvant chemotherapy: insights from a large cohort studyPeinan Liu, Dandan Liu, Changying Zhao, et al.
Pageof 2